作者
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, Kathryn Dane, Maria T DeSancho, David Diuguid, Daniel O Griffin, Susan R Kahn, Frederikus A Klok, Alfred Ian Lee, Ignacio Neumann, Ashok Pai, Marc Righini, Kristen M Sanfilippo, Deborah M Siegal, Mike Skara, Deirdra R Terrell, Kamshad Touri, Elie A Akl, Reyad Al Jabiri, Yazan Al Jabiri, Angela M Barbara, Antonio Bognanni, Mary Boulos, Romina Brignardello-Petersen, Rana Charide, Luis E Colunga-Lozano, Karin Dearness, Andrea J Darzi, Heba Hussein, Samer G Karam, Razan Mansour, Gian Paolo Morgano, Rami Z Morsi, Giovanna Muti-Schünemann, Menatalla K Nadim, Binu A Philip, Yuan Qiu, Yetiani Roldan Benitez, Adrienne Stevens, Karla Solo, Wojtek Wiercioch, Reem A Mustafa, Holger J Schünemann
发表日期
2022/9/13
期刊
Blood advances
卷号
6
期号
17
页码范围
4915-4923
出版商
American Society of Hematology
简介
Background
COVID-19–related acute illness is associated with an increased risk of venous thromboembolism (VTE).
Objective
These evidence-based guidelines from the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in making decisions about the use of anticoagulation in patients with COVID-19.
Methods
ASH formed a multidisciplinary guideline panel that included patient representatives and applied strategies to minimize potential bias from conflicts of interest. The McMaster University GRADE Centre supported the guideline development process and performed systematic evidence reviews (through November 2021). The panel prioritized clinical questions and outcomes according to their importance for clinicians and patients. The panel used the Grading of Recommendations …
学术搜索中的文章
A Cuker, EK Tseng, R Nieuwlaat, P Angchaisuksiri… - Blood advances, 2022